Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib in Progressive Multiple Sclerosis
NCT01433497Phase 3Completed
- Sponsor
- AB Science
- Start
- Aug 2011
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of masitinib in primary progressive multiple sclerosis (PPMS), secondary-progressive multiple sclerosis (SPMS), sponsored by AB Science. Started Aug 2011; status: completed.
02
Drugs
masitinib
03
Conditions
primary progressive multiple sclerosis (PPMS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT01433497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01433497.